Novel sarracinic acid derivatives bearing triazole or N-heterocyclic moiety were prepared two separate reaction schemes. The triazoles and the N-heterocyclic derivatives were synthesised using standard click chemistry approach and amination of 2-bromoethyl ester of sarracinic acid respectively. All the synthesised derivatives were screened for neuroprotective activity against corticosterone induced impairment in neuroblastoma cell line SH-SY5Y. Two analogs SA-2 and SA-12 exhibited strong neuroprotective activity. The cell viability, after high dose corticosterone induced cell death, increased remarkably with the pre treatment of SA-2 and SA-12. The biological activity of SA-2 and SA-12 was verified through docking studies. The docking studies were in good agreement with the biological results. SA-2 and SA-12 showed strong binding affinities with the target protein having ΔG = -8.88 and -7.52; inhibition constant (k) = 3.08 nM and 30.9 nM respectively.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14786419.2023.2269464 | DOI Listing |
Nat Prod Res
February 2025
Bio-organic Chemistry Division, CSIR-Indian Institute of Integrative Medicine, Srinagar, India.
Novel sarracinic acid derivatives bearing triazole or N-heterocyclic moiety were prepared two separate reaction schemes. The triazoles and the N-heterocyclic derivatives were synthesised using standard click chemistry approach and amination of 2-bromoethyl ester of sarracinic acid respectively. All the synthesised derivatives were screened for neuroprotective activity against corticosterone induced impairment in neuroblastoma cell line SH-SY5Y.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!